Corvus Pharmaceuticals
在场
Corvus Pharmaceuticals 是一家在股票代码 CRVS (US) 下上市的公司。
高管
查看带有其 12 名主要高管的组织结构图
Corvus Pharmaceuticals 搜索最多的简介
- Richard Miller, Chief Executive Officer and Chairman of the Board
- Ian Clark, Director
- Scott Morrison, Director
高管在Corvus Pharmaceuticals变化
- Jeffrey Arcara已作为Chief Business Officer加入公司 (新闻发布的2024二月7号).
- Edith Mitchell, Director, 已经去世。我们深感遗憾 (新闻发布的2024一月24号).
创建提醒
跟踪 Corvus Pharmaceuticals 的高管变动
药店
Corvus Pharmaceuticals 拥有 1,860 家竞争者，其中包括 Pfizer (美国(美洲))、Johnson & Johnson (美国(美洲)) 和 Sanofi (法国)。
Popular M&A news in 药店
- MedMen has filed for bankruptcy protection (公布2024四月28号).
- AstraZeneca has announced the acquisition of Fusion Pharma (公布2024三月23号).
- AstraZeneca has announced the acquisition of Amolyt Pharma (公布2024三月19号).
药店 行业的其他推荐联系人
消息
Corvus Pharmaceuticals 的最新新闻稿
- Corvus Pharmaceuticals Announces Pricing of $30.6 Million Registered Direct Offering | Corvus Pharmaceuticals
- Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2024 Financial Results | Corvus Pharmaceuticals
- Corvus Pharmaceuticals to Provide Business Update and First Quarter 2024 Financial Results on May 6, 2024 | Corvus Pharmaceuticals
- Corvus Pharmaceuticals Announces Initiation of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis | Corvus Pharmaceuticals
- Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results | Corvus Pharmaceuticals
- Corvus Pharmaceuticals to Provide Business Update and Fourth Quarter and Full Year 2023 Financial Results on March 19, 2024 | Corvus Pharmaceuticals
- Corvus Pharmaceuticals Announces the Passing of Board Member Edith P. Mitchell | Corvus Pharmaceuticals
- Corvus Pharmaceuticals Announces Orphan Drug Designation Granted to Soquelitinib for the Treatment of T Cell Lymphoma | Corvus Pharmaceuticals
- Press Releases | Corvus Pharmaceuticals
- Corvus Pharmaceuticals Presents Soquelitinib Preclinical Data at the Keystone Symposia on Systemic Autoimmune and Autoinflammatory Diseases | Corvus Pharmaceuticals
- View more press releases Close
通过电子邮件
